Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

ES05.04 Challenges and Solutions in Engaging With the Health Technology Assessment Process in Canada

Journal of Thoracic Oncology

English

P3.15-10 Survival Impact of Peripheral Blood Ratios in Lung Cancer According Clinical Stage

Journal of Thoracic Oncology

English

P3.01-46 Prognostic Utility of Advanced Lung Cancer Inflammation Index (ALI) in Thoracic Malignancies: A Meta-Analysis

Journal of Thoracic Oncology

English

Simultaneously Inactivating SRC and AKT by Saracatinib/Capivasertib Co-Delivery Nanoparticles to Improve the Efficacy of Anti-SRC Therapy in Head and Neck Squamous Cell Carcinoma

Journal of Hematology and Oncology

English

P3.01-73 Talc Versus Minocycline and OK-432 Pleurodesis for Malignant Pleural Effusion.

Journal of Thoracic Oncology

English

MA27.01 Establishment of PDX From Tumors Characterized by EGFR Mutations or ALK Fusion Genes From Resections, Biopsies and Pleural Fluids

Journal of Thoracic Oncology

English

127P: Maximum Treatment Response and Prophylactic Cranial Irradiation Are Important Prognostic Factors in Limited Disease Small-Cell Lung Cancer Patients Comprehensively Staged With Cranial Magnetic Resonance Imaging

Journal of Thoracic Oncology

English

P2.03-030 Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated With EGFR-TKIs

Journal of Thoracic Oncology

English

P3.03-020 Unique Molecular Profile of NSCLC in Thai Population

Journal of Thoracic Oncology

English

ES 02.04 Interventional Radiology on Personalized Medicine for Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

ES05.04 Challenges and Solutions in Engaging With the Health Technology Assessment Process in Canada

P3.15-10 Survival Impact of Peripheral Blood Ratios in Lung Cancer According Clinical Stage

P3.01-46 Prognostic Utility of Advanced Lung Cancer Inflammation Index (ALI) in Thoracic Malignancies: A Meta-Analysis

Simultaneously Inactivating SRC and AKT by Saracatinib/Capivasertib Co-Delivery Nanoparticles to Improve the Efficacy of Anti-SRC Therapy in Head and Neck Squamous Cell Carcinoma

P3.01-73 Talc Versus Minocycline and OK-432 Pleurodesis for Malignant Pleural Effusion.

MA27.01 Establishment of PDX From Tumors Characterized by EGFR Mutations or ALK Fusion Genes From Resections, Biopsies and Pleural Fluids

127P: Maximum Treatment Response and Prophylactic Cranial Irradiation Are Important Prognostic Factors in Limited Disease Small-Cell Lung Cancer Patients Comprehensively Staged With Cranial Magnetic Resonance Imaging

P2.03-030 Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated With EGFR-TKIs

P3.03-020 Unique Molecular Profile of NSCLC in Thai Population

ES 02.04 Interventional Radiology on Personalized Medicine for Lung Cancer